Self-tonometry a feasible option

Article

Glaucomatous patients can safely obtain self-tonometry measurements after applying a topical anaesthetic to their eye.

Glaucomatous patients can safely obtain self-tonometry measurements after applying a topical anaesthetic to their eye, according to a study published in the December issue of Der Ophthalmologe.

Frank Tost, MD and colleagues from the Ernst Moritz Arndt University, Germany evaluated the tolerability of Alcaine 0.5% (proparacaine; Alcon) eye drops in 100 glaucoma subjects for telemonitoring or self-tonometry. Patients were monitored using a standardized questionnaire for one year, with telemonitoring or self-tonometries performed for at least six months.

Of the 83 subjects who completed the study, none showed any significant local or systemic symptoms or side effects. However, 36.1% did experience a minor conjunctival hyperemia immediately following application of the drops. This improved within one hour in 20.4% of the subjects.

Based on these findings, the researchers concluded that self-tonometry with a topical anaesthetic can be successful.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.